what is happening with tirzepatide (Zepbound) for weight loss Does tirzepatide expire? Shelf life,

Evidence proving that chronic sub-label dosing yields similar long-term outcomes is lacking

Studies show that GLP-1 receptor agonists, drugs that mimic GLP-1, have been shown to help people with type 2 diabetes (T2D) and obesity lose weight and control their blood sugar [2]

In LEADER and SUSTAIN 6, the GLP-1 receptor agonist liraglutide was associated with an ARR of 1.5% and an HR of 0.78 (95% CI 0.67, 0.92) for new or worsening nephropathy [63], and semaglutide demonstrated an ARR of 2.3% and an HR of 0.64 (95% CI 0.46, 0.88) for new or worsening nephropathy [48]

Because we lack the specific digestive enzymes required to break down these intricate molecular bonds in the stomach and small intestine, fiber travels relatively intact into the distal small intestine and the large intestine (colon)